Loading
Loading…
Loading…
Tender Value
Refer Docs
EMD Value
₹10 L
Closing Date
13 Aug 2026, 5:00 pm4d left
As per tender document
As per tender document
e-Tender No. PMBI/DRUG/RC-235/2026 for the supply of 47 drugs to PMBI through a two years rate contract.
2026_BPPI_918658_1
PMBI/DRUG/RC-235/2026
Open Tender
Drugs and Pharmaceutical Products
Item Rate
45 days
As per tender document
As per tender document
8 documents required · 8 mandatory
₹0
₹10 L
As per tender document
23 Jul 2026
23 Jul 2026
18 Aug 2026
23 Jul 2026
13 Aug 2026
24 Jul 2026
23 Jul 2026 - 28 Jul 2026
29 Jul 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Aceclofenac Tablets IP 100 mg | 24,17,000 | 10's | - | - |
| 2 | Aspirin Gastro-resistant Tablets IP 150 mg | 79,78,000 | 14's | - | - |
| 3 | Amikacin Injection IP 250 mg per 2 ml | 63,000 | 2 ml Vial | - | - |
| 4 | Doxycycline Capsules IP 100mg | 32,15,000 | 10's | - | - |
| 5 | Famotidine Tablets IP 40 mg | 54,37,000 | 14's | - | - |
| 6 | Ondansetron Tablets IP 4 mg | 28,25,000 | 10's | - | - |
| 7 | Rabeprazole 20mg (Enteric Coated) and Domperidone 30mg (Sustained Release) Capsules | 3,04,25,000 | 10's | - | - |
| 8 | Ranitidine Tablets IP 150 mg | 2,29,80,000 | 10's | - | - |
| 9 | Folic Acid Tablets IP 5 mg | 64,85,000 | 15's | - | - |
| 10 | Budesonide Nebuliser Suspension 1mg per 2ml | 85,29,000 | 2 ml | - | - |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.39 MB
BOQ_965409.xls
BOQ • 0.36 MB
Tenderdocument235.pdf
Tender Documents • 1.63 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].